Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOBENGUANE I-131 vs IPATASERTIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IOBENGUANE I-131 vs IPATASERTIB: Safety Overview

Metric IOBENGUANE I-131 IPATASERTIB
Total FAERS Reports 123 125
Deaths Reported 13 20
Death Rate 10.6% 16.0%
Hospitalizations 25 95
Average Patient Age 22.3 yrs 61.7 yrs
% Female Patients 50.0% 57.0%
FDA Approval Date Jul 30, 2018 N/A
Marketing Status Discontinued N/A